Načítá se...
Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
The quest for the effective treatment against coronavirus disease 2019 pneumonia caused by the severe acute respiratory syndrome (SARS)‐coronavirus 2(CoV‐2) coronavirus is hampered by the lack of knowledge concerning the basic cell biology of the infection. Given that most viruses use endocytosis to...
Uloženo v:
| Vydáno v: | FEBS J |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7276759/ https://ncbi.nlm.nih.gov/pubmed/32428379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/febs.15369 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|